Savara, Inc. (SVRA)
6.025
-0.08
(-1.39%)
USD |
NASDAQ |
Dec 31, 16:00
6.03
0.00 (0.00%)
After-Hours: 16:41
Savara EPS Diluted (Quarterly): -0.1366 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| Sensus Healthcare, Inc. | -0.0578 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.56M |
| Total Expenses (Quarterly) | 29.56M |
| Enterprise Value | 1.149B |
| Earnings Yield | -8.88% |
| Normalized Earnings Yield | -8.853 |